LAURENT_SABLÉ

Pharmaceutical Institute (PHI) completes acquisition by Kelix Bio 

KELIX bio, a pan-African biopharmaceutical platform, has entered into a binding agreement to acquire Moroccan Pharmaceutical Institute (“PHI”). 

This investment marks KELIX bio’s first entry into Morocco – an important market in the company’s strategy – at a time when the Kingdom is accelerating the successful rollout of AMO (Assurance Maladie Obligatoire), a far-reaching plan to provide universal health coverage to Moroccans. 

Founded in 1988, PHI has expertise in manufacturing, promoting, and importing pharmaceutical products. 

UGGC Africa advised Pharmaceutical Institute (PHI) in this agreement with partner Laurent Sablé (pictured). 

Naciri & Associés Allen & Overy acted as legal counsel and Sijilmasa (Amine Rezzouk) acted on the financial aspects of the deal. 

Pharmaceutical Institute (PHI) completes acquisition by Kelix Bio 

suzan.taha@lcpublishinggroup.it

legalcommunitymena.com

Launched in 2022 by LC Publishing Group S.p.A., it is the first digital portal addressed to the Middle East North Africa market.

In terms of contents, the website focuses on both law firms and in-house legal departments, covering the latest news and rumors on deals and operations (and the related advisors) as well as on laterla hires, moves and new appointmens and providing insights, analytical data and opinions on the professions’ main trends and topics (AI, innovation, etc.).

For further information, please visit the Group’s website www.lcpublishinggroup.com

Legalcommunity MENA
LC Publishing Group S.p.A. – Via Tolstoi 10 – 20146 Milano – Tel. 0236727659 – C.F./P.IVA 07619210961
REA 1971432 Registro delle Imprese di Milano – Cap. Soc. Euro 50.000,00 i.v.

Copyright 2022 © All rights Reserved. Design by Origami Creative Studio

SHARE

Share on linkedin
Share on twitter
Share on facebook
Share on whatsapp
Share on email
Share on telegram